Last month, the FDA granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract developed by Munich-based Vertanical. Two large Phase 3 clinical trials showed it outperformed opioids for chronic low back pain, with no dependence and no withdrawal. The designation is reserved for drugs showing substantial improvement over existing therapies in serious conditions — the highest scientific signal the FDA sends before approving a medicine.
I have been growing, formulating, using and talking about CBD for nearly a decade. I want to discuss what this means.
What it means
It means the scientific establishment is confirming that full-spectrum cannabis compounds have genuine medical value for pain. The ELEVATE trial enrolled 384 patients across four countries. The placebo-controlled study enrolled 820.
For the sixty million Americans living with chronic pain this is significant. One in five of these people are still being prescribed opioids for want of alternatives. The pharmaceutical pathway is long. VER-01 won’t be FDA-approved in the United States until 2028 at the earliest. But the direction is hopeful.
Cannabis compounds can treat pain. That science and the FDA are acknowledging this will pave the way for readily accessible and refined CBD remedies.
What it doesn’t mean
CBD gets over-hyped in marketing and in media. Vertanical itself drew this line explicitly: VER-01’s findings cannot be extrapolated to other cannabis extracts. That is not a footnote. Vertanical spent $250 million on the research telling you, in plain language, that their specific standardized extract from a specific proprietary strain is not the same thing as the CBD tincture on the shelf at your local health food store.
Full-spectrum matters. Source matters. Formulation matters. Testing matters. The gap between a pharmaceutical-grade standardized extract and what most Americans can buy right now is important.
I am not saying consumer CBD does not work. I have spent ten years formulating it because I believe it does, and because it worked for me when I needed it. I am saying that VER-01’s results do not give every CBD brand permission to imply their products do the same thing.
A Collision of Laws
What makes this week genuinely strange is the collision happening in Washington at the same time.
The FDA is signaling that full-spectrum cannabis medicine is real, significant, and worthy of accelerated review. Congress, meanwhile, is moving toward a federal standard that would effectively ban most hemp-derived CBD products from the market by November 2026. Oregon has already pulled unregistered CBD products from shelves since June 1st.
One branch of the federal government is validating cannabis medicine. Another is trying to restrict it.
I have been talking to legislators, testifying at hearings, and educating on this subject for years. The argument I have always made is simple: CBD is not intoxicating, it is genuinely helpful to a lot of people, and the patients who rely on it are not the problem the regulators are trying to address.
That argument just got a healthy boost from the science community. What happens next in Congress will say a great deal about whether American health policy is being driven by evidence or by something else.
What I would tell someone with chronic pain today
Talk to your doctor. That is not a deflection. It matters more now than it did a month ago, because the conversation is changing. Your physician may not have read about VER-01. Show them. Ask questions. The endocannabinoid system is very real, and research is evolving daily. Your healthcare provider and you should both understand how CBD may work for you.
If you are using CBD and it helps you, do not let the regulatory noise get in the way. Anything you are ingesting or using for pain should be regulated. But many new laws are based solely on restricting intoxicating substances which are being marketed using CBD as a cover. Those items should be scrutinized and regulated.
CBD remedies should be sourced carefully. Ask for a Certificate of Analysis. Understand the various ways CBD is delivered and why that is important. Full spectrum, Broad Spectrum and Isolates are different forms of CBD extract and they work differently. It is worth taking the time to understand those variables.
If you are a physician, a regulator, or a policymaker reading this: the science is no longer an obstacle. The hemp industry and patients figured this out a long time ago. They need your help and guidance in getting the most out of an underused, plant based and non-addictive pain remedy.